Abiopharma

🔍 Dobkin Arkadiy (Director)

Company: EPAM Systems, Inc. (EPAM)

Report Date: 2026-03-25

Detailed Transactions and Holdings:

• Acquired 41,026 shares of EPAM Common Stock at $70.52 per share (Direct)
  Date: 2026-03-25 | Code: M | equity_swap_involved: 0 | shares_owned_after: 1,363,847.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 30,082 shares of EPAM Common Stock at $133.26 per share (Direct)
  Date: 2026-03-25 | Code: F | equity_swap_involved: 0 | shares_owned_after: 1,333,765.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 41,026 shares of Employee Stock Option (right to buy) at $70.52 per share (Derivative)
  Date: 2026-03-25 | Code: M | Expires: 2026-03-25 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: The stock option was automatically exercised on a net share settlement basis immediately before its expiration, in accordance with its terms. The Company delivered to the reporting person the number of shares underlying the stock option less the number of shares having a Fair Market Value on the date of such exercise equal to (i) the aggregate exercise price for the stock option and (ii) the amount necessary to satisfy any federal, state and local withholding taxes related to such exercise.
• F2: The option became exercisable as to 25% of the shares on each of March 25, 2017, 2018, 2019 and 2020.